Receptos Names CFO

San Diego-based Receptos, a developer of treatments for immune and metabolic disease, said this week that it has named Graham Cooper as its Chief Financial Officer. Cooper has previously served as CFO of Geron Corporation and Orexigen Therapeutics. Receptos said that Cooper was SVP and CFO of Orexigen, through $300M in funding, including an $80M IPO. He also has served at Deutsche Bank and Deloitte & Touche.